This PDF is the current document as it appeared on Public Inspection on 01/08/2014 at 08:45 am.
Department of the Army, DoD.
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/826,820, entitled “Small-Molecule Antidotes to Ribosome-Inactivating Proteins,” filed on May 23, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
The invention relates to a method of treating, inhibiting, reducing, or preventing intoxication caused by a ribosome-inactivating (RIP) in a subject which comprises administering to the subject a therapeutically effective amount of at least one compound or composition according to the present invention.Start Signature
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-00146 Filed 1-8-14; 8:45 am]
BILLING CODE 3710-08-P